Skip to main content
FinSpry Logo
FinSpry
EXEL logo
EXEL
(NASDAQ)
Exelixis, Inc.
$51.35-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Exelixis (EXEL) Stock Price & Financial Analysis

Exelixis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$50.80 - $52.95
52-Week High$53.93
52-Week Low$33.76
Open$52.00
Volume3.50M
Average Volume (3M)2.58M
Market Cap13.73B
Shares Outstanding267.32M
P/E Ratio (TTM)16.47
Forward P/E13.23
Price to Sales (P/S)5.78
Price to Book (P/B)7.09
EV/EBITDA13.92
Revenue (TTM)2.38B
Net Income (TTM)833.42M
Free Cash Flow (TTM)911.16M
EPS (TTM)$3.00
Profit Margin35.08%
Operating Margin39.43%
Return on Equity (ROE)43.05%
Debt to Equity0.09
50-Day MA$48.64
200-Day MA$43.56
52-Week Change27.20%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Exelixis

What is the current stock price for EXEL?

As of the latest trading session, EXEL stock trades at $51.35. The 52-week range is $33.76–$53.93, with a day range of $50.80–$52.95.

What is the P/E ratio for EXEL?

Exelixis's trailing P/E ratio is 16.5, meaning investors pay $16.5 for every $1 of annual earnings. The forward P/E is 13.2, reflecting analyst expectations for future earnings. Exelixis operates in the Healthcare sector.

Does EXEL pay dividends?

Exelixis does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EXEL?

Based on 10 analysts, the consensus for EXEL is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EXEL?

Exelixis's market capitalization is $13.73B, classifying it as a large-cap company. Exelixis operates in the Healthcare sector within the Biotechnology industry.